Whitepaper: Japan Drug Loss

Japan, the world’s third-largest pharmaceutical market, is undergoing transformative reforms in its pharmaceutical and medical device regulations. These changes are creating unprecedented opportunities for foreign drug developers to bring their innovative solutions to Japanese patients.

Are you ready to Unlock your $92 billion market opportunity with recent changes in Japan’s Market?

Please click below to learn more about this new and exciting opportunity in Japan!

About the author.

administrator

20 years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol-Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.

TYPE & ENTER: